Trial Profile
A Phase Ib/II Study of LEE011 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ribociclib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 28 Jan 2021 Status changed from recruiting to discontinued.
- 09 Oct 2018 Planned End Date changed from 1 Sep 2018 to 1 Sep 2021.
- 09 Oct 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Sep 2020.